Petros Pharmaceuticals (PTPI) announces a new collaboration with Lemonaid Health, telemedicine provider and a subsidiary of 23andMe (ME), serving hundreds of thousands of patients with quality healthcare. As part of the collaboration, prescription STENDRA in all strengths will be available through Lemonaid Health’s telehealth platform. This collaboration allows Lemonaid Health to work directly with Petros, resulting in expanded distribution, and better access for patients.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PTPI: